Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 14;15(14):3142.
doi: 10.3390/nu15143142.

Diet Plus Inositols, α-Lactalbumin and Gymnema sylvestre: The Successful Combo to Restore Body Weight and Metabolic Profile in Obese and Dysmetabolic Patients

Affiliations

Diet Plus Inositols, α-Lactalbumin and Gymnema sylvestre: The Successful Combo to Restore Body Weight and Metabolic Profile in Obese and Dysmetabolic Patients

Sabrina Basciani et al. Nutrients. .

Abstract

The primary control of dysmetabolic patients is extremely challenging worldwide, with inadequate dietary habits and sporadic physical activity among the key risk factors for metabolic syndrome onset. Nowadays, there is no exclusive treatment for this condition, and considering that preventive measures usually fail, new therapeutic approaches need to be proposed and investigated. This present pilot study compared the effects of diet alone and in association with a combination of myo-inositol and d-chiro-inositol in their 40:1 ratio, α-lactalbumin, and Gymnema sylvestre on different metabolic parameters in obese dysmetabolic patients. To this purpose, 37 patients with BMI between 30 and 40 and fasting blood glucose between 100 and 125 mg/dL were divided into two groups: (i) the control group followed a hypocaloric Mediterranean diet, (ii) while the study group was also supplemented with a daily dosage of two sachets, each one containing 1950 mg myo-inositol, 50 mg d-chiro-inositol, 50 mg α-lactalbumin, and 250 mg Gymnema Sylvestre. After a 6-month treatment, all parameters improved in both groups. Nevertheless, the treated group experienced a greater improvement, especially concerning the variation from the baseline of HOMA index, triglycerides, BMI, body weight, and waist circumference. These findings support the supplementation with myo-inositol and d-chiro-inositol in the 40:1 ratio, α-lactalbumin, and Gymnema sylvestre as a therapeutical strategy to potentiate the beneficial effects induced via dietary programs in dysmetabolic patients.

Keywords: Gymnema sylvestre; d-chiro-inositol; diet; gut microbiota; insulin-sensitizing effect; intestinal inflammation; lifestyle; myo-inositol; α-lactalbumin.

PubMed Disclaimer

Conflict of interest statement

S.D. and V.U. are employed at Lo.Li. Pharma S.r.l., Rome (Italy).

Figures

Figure 1
Figure 1
Absolute variation (Δ) of HOMA index (A), triglycerides (B), BMI (C), weight (D), and waist circumference (E) from baseline to 6 months between treated (hypocaloric Mediterranean diet plus inositols, α-LA, and Gymnema sylvestre) and control groups (hypocaloric Mediterranean diet); all Δ were significant with p-value < 0.05.

References

    1. Cankurtaran M., Halil M., Yavuz B.B., Dagli N., Oyan B., Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Arch. Gerontol. Geriatr. 2006;42:35–45. doi: 10.1016/j.archger.2005.05.004. - DOI - PubMed
    1. Saklayen M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018;20:12. doi: 10.1007/s11906-018-0812-z. - DOI - PMC - PubMed
    1. GBD 2019 Risk Factors Collaborators Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–1249. doi: 10.1016/S0140-6736(20)30752-2. - DOI - PMC - PubMed
    1. Bizzarri M., Fuso A., Dinicola S., Cucina A., Bevilacqua A. Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease. Expert. Opin. Drug Metab. Toxicol. 2016;12:1181–1196. doi: 10.1080/17425255.2016.1206887. - DOI - PubMed
    1. Greff D., Juhász A.E., Váncsa S., Váradi A., Sipos Z., Szinte J., Park S., Hegyi P., Nyirády P., Ács N., et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Reprod. Biol. Endocrinol. 2023;21:10. doi: 10.1186/s12958-023-01055-z. - DOI - PMC - PubMed